Gastón Morán
Gastón Morán is a biochemist recently appointed as the new director of the National Institute of Medicines (INAME) in Argentina, following a scandal involving contaminated fentanyl that led to numerous fatalities. A graduate of the University of Morón, he holds a master's degree in Public Policy from Austral University and a postgraduate degree in Pharmaeconomics from Isalud University. Morán has extensive experience within the ANMAT, having served in various roles, including as the director of biological product evaluation and control. His appointment comes at a critical time as the agency seeks to restore confidence in its ability to oversee drug safety and quality amidst a public health crisis.
Not in the pool (under ¢1).
Recent news mentions
Gastón Morán is the new director of the Instituto Nacional de Medicamentos.
el fármaco que quedó en la mira
Argentina· 2025-10-07
Morán is the new director of INAME who accelerated the review of pending files leading to the closure of six laboratories.
Clausuran un importante laboratorio tras detectar que un remedio clave no generaba el efecto prometidoArgentina· 2025-10-01Gastón Morán replaced Gabriela Mantecón as the head of INAME.
los medicamentos que sacaron del mercadoArgentina· 2025-09-15
Gastón Morán assumed office on August 21, leading to increased controls and administrative measures against pharmaceutical laboratories.
Clausuran el cuarto laboratorio farmacéutico en 20 días y retiran del mercado una droga contra la leucemiaArgentina· 2025-09-12
Gastón Morán was recently appointed as the new Director of INAME by the National Government.
Tras el caso fentanilo contaminado, la Anmat ordenó retirar del mercado dos productos e inhibió a un laboratorioArgentina· 2025-09-01
Gastón Morán was appointed as the new director of the National Institute of Medicines (INAME) following the removal of Gabriela Mantecón Fumadó.
Quién es el reemplazante de la funcionaria de la ANMAT desplazada por el escándalo del fentanilo contaminadoArgentina· 2025-08-22
